Insider Transactions in Q2 2020 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Open market or private sale
|
Direct |
39,583
-5.94%
|
$22,285,229
$563.01 P/Share
|
|
May 07
2020
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,809
-73.78%
|
$1,016,658
$562.0 P/Share
|
|
May 06
2020
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
15,000
-30.68%
|
$8,460,000
$564.38 P/Share
|
|
May 06
2020
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+47.13%
|
$2,655,000
$177.82 P/Share
|
|
May 06
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
45,996
-29.18%
|
$25,527,780
$555.77 P/Share
|
|
May 06
2020
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Exercise of conversion of derivative security
|
Direct |
85,579
+35.19%
|
$4,450,108
$52.03 P/Share
|
|
May 06
2020
|
Michael S Brown Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,661
-32.56%
|
$2,031,855
$555.77 P/Share
|
|
May 06
2020
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,470
+27.97%
|
$1,777,750
$325.18 P/Share
|
|
May 06
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
50,124
-5.62%
|
$27,518,076
$549.34 P/Share
|
|
May 06
2020
|
Arthur F Ryan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
50,124
+11.66%
|
$17,994,516
$359.12 P/Share
|
|
May 06
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,000
-20.74%
|
$1,120,000
$560.0 P/Share
|
|
May 06
2020
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
2,000
-7.59%
|
-
|
|
May 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$52,200
$522.39 P/Share
|
|
Apr 20
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
5,300
-2.54%
|
$3,005,100
$567.48 P/Share
|
|
Apr 20
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
3,250
-1.12%
|
$1,842,750
$567.79 P/Share
|
|
Apr 17
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
6,322
-14.61%
|
$3,508,710
$555.82 P/Share
|
|
Apr 17
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
11,622
+21.07%
|
$685,698
$59.2 P/Share
|
|
Apr 17
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
2,267
-0.81%
|
$1,258,185
$555.4 P/Share
|
|
Apr 17
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,250
-25.09%
|
$5,133,750
$555.82 P/Share
|
|
Apr 17
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+25.32%
|
$3,400,000
$272.7 P/Share
|
|
Apr 17
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
991
-0.28%
|
$550,005
$555.42 P/Share
|
|
Apr 16
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
2,733
-14.06%
|
$1,445,757
$529.79 P/Share
|
|
Apr 16
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.46%
|
$295,000
$59.2 P/Share
|
|
Apr 16
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,009
-10.61%
|
$1,591,761
$529.79 P/Share
|
|
Apr 16
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+12.36%
|
$1,088,000
$272.7 P/Share
|
|
Apr 15
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
853
-0.57%
|
$442,707
$519.71 P/Share
|
|
Apr 15
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
2,262
-1.44%
|
$1,173,978
$519.4 P/Share
|
|
Apr 14
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,647
-9.5%
|
$1,379,087
$521.45 P/Share
|
|
Apr 14
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.16%
|
$952,000
$272.7 P/Share
|
|
Apr 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
2,738
-14.09%
|
$1,426,498
$521.45 P/Share
|
|
Apr 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.46%
|
$295,000
$59.2 P/Share
|
|
Apr 14
2020
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
5,497
-5.36%
|
$2,858,440
$520.68 P/Share
|
|
Apr 13
2020
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,582
-31.0%
|
$3,874,402
$511.56 P/Share
|
|
Apr 13
2020
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,079
+34.84%
|
$680,108
$52.03 P/Share
|
|
Apr 13
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
828
-0.37%
|
$421,452
$509.95 P/Share
|
|
Apr 09
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,672
-9.59%
|
$1,357,376
$508.25 P/Share
|
|
Apr 09
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.16%
|
$952,000
$272.7 P/Share
|
|
Apr 07
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
696
-1.39%
|
$348,000
$500.15 P/Share
|
|
Apr 06
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,304
-8.42%
|
$1,149,696
$499.95 P/Share
|
|
Apr 06
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.88%
|
$816,000
$272.7 P/Share
|
|
Apr 03
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
683
-0.28%
|
$337,402
$494.85 P/Share
|
|
Apr 02
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
433
-0.3%
|
-
|
|
Apr 02
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
6,797
-2.7%
|
$3,330,530
$490.97 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,353
-0.35%
|
$662,970
$490.51 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,317
-8.07%
|
$1,139,964
$492.05 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.46%
|
$816,000
$272.7 P/Share
|
|
Apr 01
2020
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
1,200
-0.67%
|
$584,400
$487.35 P/Share
|
|
Apr 01
2020
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+7.74%
|
$36,000
$30.63 P/Share
|
|
Apr 01
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
8,203
-12.71%
|
$4,003,064
$488.22 P/Share
|
|
Apr 01
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.83%
|
$885,000
$59.2 P/Share
|